Fortitude Family Office’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.25K | Sell |
1,553
-118
| -7% | -$551 | ﹤0.01% | 658 |
|
|
2025
Q1 | $9.17K | Hold |
1,671
| – | – | ﹤0.01% | 557 |
|
|
2024
Q4 | $5.67K | Hold |
1,671
| – | – | ﹤0.01% | 801 |
|
|
2024
Q3 | $4.76K | Hold |
1,671
| – | – | ﹤0.01% | 806 |
|
|
2024
Q2 | $3.76K | Sell |
1,671
-638
| -28% | -$1.44K | ﹤0.01% | 680 |
|
|
2024
Q1 | $5.1K | Hold |
2,309
| – | – | ﹤0.01% | 601 |
|
|
2023
Q4 | $5.43K | Buy |
+2,309
| New | +$5.43K | ﹤0.01% | 580 |
|